CURRICULUM VITAE
Tamara Đurić, PhD
Institute of Nuclear Sciences "Vinča"
Laboratory for Radiobiology and Molecular Genetics
P.O. Box 522, 11001 Belgrade, Serbia
Phone: 381 11 3408566
Fax: 381-11-2447485
e-mail: tamariska@vinca.rs
EDUCATION:
2000. BSc work titled „ Molecular mechanisms of acting and appearance of physical dependence
on alcohol and benzodiazepines ”, University of Belgrade, Faculty of Life sciences, Department of
Molecular Biology and Physiology, Group of Experimental Biomedicine.
2001. Finished postgraduate studies on AAEN (Alternative Academic Educational Network) within
the programme : Environment challenge for Science, Technology and Society; get the highest grade
(min D, max A) on final exam titled: “Environment and nutrition as a cause of appearance of
oxidative stress and its influence on atherosclerosis”.
2004. Finished postgraduate studies on University of Belgrade: Faculty of Life Sciences,
Department of Molecular biology and biochemistry and got the MSc degree. The title of the final
exam was: “Interaction of matrix metalloproteinase-3 (stromelysin-1) and endothelial nitric oxide
synthase gene polymorphisms with cardiovascular disease common risk factors in human
population.”
2008. Finished PhD studies on University of Belgrade: Faculty of Life Sciences, Department of
Molecular biology and biochemistry and got the PhD degree. The title of the final exam was:
“Molecular epidemiology of carotid athereosclerosis: genetic polymorphisms in human matrix
metalloproteinase family.”
PROFESSIONAL APPOINTMENTS:
2001- present employed in Institute of Nuclear Sciences „ Vinca ”, Laboratory for Radiobiology
and Molecular Genetics. Working as a research associate on genetic epidemiology of vascular
diseases.
Position:
2002. research trainee
2004. research assistant
2008. research associate
PROJECT PARTICIPATION:
1. 2011-2014. “Genetic basis of vascular and inflammatory human diseases” funded by Republic
Ministry of Science and Technology, (Project OI 175085), Institute of Nuclear Sciences
“VINCA”, Medical Faculty, University of Belgrade, Belgrade,
2. 2011-2014. »An integral study to identify the regional genetic and environmental risk factors
for the common noncommunicable diseases in the human population of Serbia« funded by
Republic Ministry of Science and Technology, (Project III 41028), Institute of Nuclear
Sciences “VINCA”, Belgrade, (head Dr Dragan Alavantic),
3. 2008-2009. “Application of Radiation research and Genetic epidemiology in estimation of risk
of chronic noncommunicable diseases in population of Obrenovac Municipality” funded by
Republic Ministry of Science and Technology, (Project TR 23040), Institute of Nuclear
Sciences “VINCA”,
4. 2005-2010. “Genetic epidemiology and pharmacogenomics of vascular diseases” funded by
Republic Ministry of Science and Technology, (Project M145023), “VINCA” Institute of
Nuclear Sciences, Belgrade, (head Dr Dragan Alavantic),
5. 2002- 2005. Genetic Epidemiology of Vascular Diseases, funded by Republic Ministry of
Science and Technology, (Project 2011) Institute of nuclear sciences “Vinca”, (head Dr Dragan
Alavantic), Investigator
INTERNATIONAL COLLABORATIONS
2009-2011. Bilateral Project Serbia Slovenia, Genetics of Multiple Sclerosis, Serbian Republic
Ministry of Science and Technology. Investigator
2008-2010. Bilateral Project Serbia-Croatia, Genetics of Multiple Sclerosis, Serbian Republic
Ministry of Science and Technology. Investigator
2004-2006. Perticipation in: European Commission Framework Programme: Equal Project (EC4):
Multi-National External Quality Assay (EQA) Programmes in Clinical Molecular Diagnostics based
on Performance and Interpretation of PCR assay including dissemination and training, supported by
the European Community within the FP6 programme.
2003. The third European-American School in Forensic Genetics and Mayo Clinic Course in
Advanced Molecular and Cellular Medicine, September 1-5, Zagreb, Croatia
2003. Short term treinee in the BRC (Biological Research Center), Department of Genetics in
Szeged, Hungary, on the project: ”Population genetic studies by the means of mitochondrial DNA
and Y chromosome specific markers from ancient bones”.
TRAINEES:
1 BsC
PUBLISHED PEER REVIEWED ARTICLES:
Total number of publications in SCI Journals: 10
Total number of abstracts presented: 30
SELECTED PUBLICATIONS:
1.
Djurić T, Zivković M, Stanković A, Kolaković A, Jekić D, Selaković V, Alavantić D.
Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis. J Clin Lab
Anal. 2010, 24(4):246-51.
2.
Stanković A, Dincić E, Ristić S, Lovrecić L, Starcević Cizmarević N, Djurić T, Sepcić J,
Kapović M, Raicević R, Peterlin B, Alavantić D, Zivković M. Interleukin 7 receptor alpha
polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans. Mult
Scler. 2010. 16(5):533-6.
3.
Djurić T, Umićević M, Koncar I, Zivković M, Vasić D, Davidović L, Stanković A,
Alavantić D. Lack of association between eNOS Glu298Asp gene polymorphism and carotid
atherosclerosis in a Serbian population. Clin Chem Lab Med. 2009, 47(12):1573-5.
4.
Djurić T, Živković M, Stanković A, Dincić E, Raicević R, Alavantić D. Association of the
MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. Jornal of
Neurological Sciences 2008, 267(1-2)62-65.
5.
Djurić T, Živković M, Radak Dj, Jekić Dj, Radak S, Stojković Lj, Raičević R, Stanković A,
Alavantić D. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid
atherosclerosis. Clinical Biochemistry 2008, 41(16-17):1326-1239.
6.
Zivković M, Djurić T, Stancić O, Alavantić D, Stanković A. X-linked angiotensin II type 2
receptor gene polymorphism -1332A/G in male patients with essential hypertension. Clinica
Chimica Acta 2007, 386:110-113.
7.
Živković M, Djurić T, Dincić E, Raicević R, Alavantić D, Stanković A. Matrix
metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.
Journal of Neuroimmunology, 2007, 189(1-2):147-150.
8.
Djuric T, Zivkovic M, Stankovic A, Mecanin S, Alavantic D. Endothelial NOS G894 T and
MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population. J Clin Lab Anal,
2005, 19(6):241-246.